Treatments, complications, and healthcare utilization associated with acromegaly: A study in two large United States databases

Pituitary

Volumn 17, Issue 4, 2014, Pages 333-341

  Broder, M S ^a   Neary, M P ^b   Chang, E ^a   Cherepanov, D ^a   Katznelson, L ^c  

^a PARTNERSHIP FOR HEALTH ANALYTIC RESEARCH   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acromegaly; Complications; Economics; Growth hormone (GH); Insulin like growth factor 1 (IGF 1); Treatment

Indexed keywords

ANGIOPEPTIN; DOPAMINE RECEPTOR STIMULATING AGENT; GROWTH HORMONE; LONG ACTING DRUG; OCTREOTIDE; PEGVISOMANT; SHORT ACTING DRUG; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGE DISTRIBUTION; AGED; ARTHRALGIA; ARTICLE; BRAIN RADIATION; BRAIN SURGERY; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARPAL TUNNEL SYNDROME; COLON POLYP; COLON TUMOR; COMORBIDITY; CROSS-SECTIONAL STUDY; DATA BASE; DIABETES MELLITUS; DRUG MONITORING; EMERGENCY CARE; ENDOCRINOLOGIST; FEMALE; GALACTORRHEA; GENITAL SYSTEM DISEASE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART ARRHYTHMIA; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOPHYSIS TUMOR; HYPOPITUITARISM; IMPOTENCE; INFERTILITY; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MALE; MENSTRUATION DISORDER; MIDDLE AGED; MUSCULOSKELETAL DISEASE; OSTEOARTHRITIS; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SEX DIFFERENCE; SLEEP DISORDERED BREATHING; SYNOVITIS; UNITED STATES; YOUNG ADULT; ADOLESCENT; COMPLICATION; ECONOMICS; FACTUAL DATABASE;

ACROMEGALY; ADOLESCENT; ADULT; AGED; DATABASES, FACTUAL; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; UNITED STATES; YOUNG ADULT;

EID: 84904101849     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-013-0506-0     Document Type: Article

References (18)

1. Ben-Shlomo A, Sheppard M, Stephens J, Pulgar S, Melmed S (2011) Clinical, quality of life, and economic value of acromegaly disease control. Pituitary 14(3):284-294
2. Melmed S (2006) Medical progress: acromegaly. N Engl J Med 355(24):2558-2573
3. Chanson P, Salenave S, Kamenicky P et al (2009) Acromegaly. Best Pract Res Clin Endocrinol Metab 23(5):555-574
4. Dekkers O, Biermasz N, Pereira A, Romijn J, Vandenbroucke J (2008) Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab 93(1):61-67
5. Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25(1):102-152 (Pubitemid 38269977)
6. O'Malley A, Pham H, Schrag D, Wu B, Bach P (2007) Potentially avoidable hospitalizations for COPD and pneumonia: the role of physician and practice characteristics. Med Care 45:562-570
7. Agency for Healthcare Research and Quality (AHRQ): HCUP Chronic Condition Indicator. Healthcare Cost and Utilization Project (HCUP). AHRQ. www.hcup-us.ahrq.gov/toolssoftware/chronic/chronic.jsp. Accessed 5 Sep 2012
8. Hwang W, Heller W, Ireys H, Anderson G (2001) Out-of-pocket medical spending for care of chronic conditions. Health Aff 20:267-278 (Pubitemid 33707460)
9. Charlson M, Pompei P, Ales K, MacKenzie C (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373-383 (Pubitemid 17055592)
10. Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45(6):613-619
11. Ezzat S, Serri O, Chik CL et al (2006) Canadian consensus guidelines for the diagnosis and management of acromegaly. Clin Invest Med 29(1):29-39
12. Burton T, Le Nestour E, Bancroft T, Neary M (2013) Real-world comorbidities and treatment patterns of patients with acromegaly in two large US health plan databases. Pituitary 16(3):354-362
13. Katznelson L, Atkinson J, Cook D, Ezzat S, Hamrahian A, Miller K (2011) AACE Acromegaly Task Force. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly - 2011 update. Endocr Pract 17(4):1-44
14. Wier L, Pfuntner A, Maeda J, Stranges E, Ryan K, Jagadish P, Collins Sharp B, Elixhauser A (2011) HCUP facts and figures: statistics on hospital-based care in the United States, 2009. Agency for Healthcare Research and Quality. http://www.hcup-us.ahrq.gov/reports.jsp. Accessed 17 Oct 2012
15. Didoni G, Grottol S, Gasco V et al (2004) Cost-of-illness study in acromegalic patients in Italy. J Endocrinol Invest 27(11):1034-1039
16. Wilson L, Shin J, Ezzat S (2001) Longitudinal assessment of economic burden and clinical outcomes in acromegaly. Endocr Pract 7(3):170-180 (Pubitemid 32514872)
17. Knutzen R, Ezzat S (2006) The cost of medical care for the acromegalic patient. Neuroendocrinology 83:139-144 (Pubitemid 44578865)
18. Tyree P, Lind B, Lafferty W (2006) Challenges of using medical insurance claims data for utilization analysis. Am J Med Qual 21(4):269-275 (Pubitemid 44035786)